Introduction: MS-based mostly Covalent Binding Analysis permits processing of about two hundred samples each day to competently evaluate kinetic parameters and optimize covalent inhibitor drug discovery. day-to-day laboratory workflows frequently encounter bottlenecks in exactly characterizing covalent drug interactions. Researchers striving to co